stockrow
Friday 6 November 2026
Export HSIC’s income statement to Excel — free account
Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
87.27
1.96
+2.30%
Follow HSIC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
22.38 | 24.14 | 22.07 | 22.90 |
+8 more quarters Free account |
P/S ratio |
0.68 | 0.70 | 0.63 | 0.69 | |
P/FCF ratio |
16.71 | 16.65 | 19.04 | 15.94 | |
P/Operating CF |
58.03 | 39.15 | (87.33) | 23.97 | |
P/B ratio |
2.45 | 2.48 | 2.16 | 2.34 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.85 | 0.86 | 0.80 | 0.86 | |
EV/EBITDA |
11.22 | 11.69 | 10.94 | 11.74 | |
EV/Operating CF |
17.01 | 16.79 | 18.50 | 15.90 | |
EV/FCF |
20.90 | 20.66 | 24.03 | 19.75 | |
Quick Ratio |
0.57 | 0.55 | 0.56 | 0.56 | |
Current Ratio |
1.33 | 1.32 | 1.36 | 1.38 | |
Net Debt/EBITDA |
8.39 | 8.95 | 8.46 | 8.96 | |
Debt/Assets |
21.93% | 21.42% | 20.90% | 20.89% | |
Debt/Equity |
0.66 | 0.64 | 0.60 | 0.60 | |
Asset Turnover |
1.22 | 1.22 | 1.23 | 1.23 | |
Operating CF/Net income |
1.35 | 2.57 | (0.91) | 3.77 | |
Capex/Depreciation |
(0.35) | (0.36) | (0.31) | (0.53) | |
Interest Coverage |
4.60 | 3.98 | 4.67 | 4.18 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.60% | 24.03% | 24.02% | 23.51% | |
Intangible Assets out of Total Assets |
0.45 | 0.46 | 0.47 | 0.47 | |
Share Based Compensation of Revenue |
0.29% | 0.38% | 0.09% | 0.29% | |
Graham Net Nets |
(0.31) | (0.31) | (0.34) | (0.31) | |
Graham Number |
53.82 | 51.18 | 50.62 | 48.95 | |
Earnings Yield |
4.47% | 4.14% | 4.53% | 4.37% | |
Free Cash Flow Yield |
5.98% | 6.01% | 5.25% | 6.28% | |
Revenue per Share |
31.19 | 30.48 | 29.30 | 28.45 | |
Operating CF per Share |
1.45 | 2.13 | (0.84) | 3.15 | |
Capex per Share |
(0.27) | (0.26) | (0.22) | (0.36) | |
Free Cash Flow per Share |
1.18 | 1.87 | (1.06) | 2.80 | |
Cash per Share |
1.65 | 1.38 | 1.20 | 1.29 | |
Shareholders Equity per Share |
34.30 | 33.64 | 34.10 | 32.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
34.30 | 33.64 | 34.10 | 32.27 | |
Free Cash Flow |
131.00 | 212.00 | (122.00) | 338.00 | |
Working Capital |
1,178.00 | 1,112.00 | 1,199.00 | 1,236.00 | |
Capital Expenditures |
(30.00) | (30.00) | (25.00) | (43.00) | |
Net Current Asset Value |
(2,917.00) | (2,964.00) | (2,889.00) | (2,852.00) | |
EV/EBIT |
16.48 | 17.29 | 16.20 | 17.33 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
13.18 | 13.93 | 12.84 | 13.98 | |
| Other line items | |||||
Average Receivables |
1,809.00 | 1,704.00 | 1,648.50 | 1,566.50 | |
Average Payables |
1,119.00 | 1,026.50 | 975.50 | 1,058.00 | |
Average Inventory |
1,981.00 | 1,983.50 | 1,928.00 | 1,906.00 | |
Average Assets |
11,303.50 | 11,143.50 | 10,892.00 | 10,716.50 | |
Average Common Equity |
3,920.00 | 3,952.50 | 3,936.50 | 3,965.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026